pharma · Dermatomyositis · Diffuse Cutaneous Systemic Sclerosis · CRBP
Corbus Pharmaceuticals
Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 500 River Ridge Dr, Norwood, Massachusetts 02062, US
- Founded
- 2014
- Employees
- 57
- Programs
- 11
- Drugs
- 3
- Patents
- 6
Corbus Pharmaceuticals clinical trials
Registry index of 11 ClinicalTrials.gov studies linked to Corbus Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Corbus Pharmaceuticals trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Corbus Pharmaceuticals.
-
JBT-101 — Phase 2
Clinical update -
CRB-601 monoclonal antibody — Phase 2
Clinical update -
A Clinical Trial for Patients with Advanced Cancers — Phase 2
Clinical update -
Lenabasum 20 mg — Phase 3
Clinical update -
Lenabasum 5 mg — Phase 3
Clinical update -
CRB-701 — Phase 2
Clinical update -
JBT-101 — Phase 2
Clinical update -
JBT-101 — Phase 2
Clinical update